Karen Prange
CIK: 0001566083
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Aug 5, 2026ATRC
AtriCure, Inc.
Sale(S)Direct3.6K shares at avg. $38.80$138K - Jun 4, 2026OM
Outset Medical, Inc.
Award(A)Direct10.7K shares- - May 20, 2026ATRC
AtriCure, Inc.
Sale(S)Direct3K shares at avg. $28.65$86K - May 18, 2026ATRC
AtriCure, Inc.
Award(A)Direct6.1K shares- - Feb 11, 2026EMBC
Embecta Corp.
Award(A)Direct22.8K shares- - Jan 9, 2026OM
Outset Medical, Inc.
Award(A)Direct18.7K shares- - May 19, 2025ATRC
AtriCure, Inc.
Award(A)Direct5.4K shares- - Apr 3, 2025NVRO
NEVRO CORP
Disposition(D)Direct33.9K shares- - Mar 5, 2025ATRC
AtriCure, Inc.
Sale(S)Direct6.1K shares at avg. $38.12$233K - Feb 12, 2025EMBC
Embecta Corp.
Award(A)Direct13.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 5, 2026 |  ATRC AtriCure, Inc. | Sale(S) | 3,564 | $38.80 | $138,283 | Direct |
| Jun 4, 2026 |  OM Outset Medical, Inc. | Award(A) | 10,667 | - | $0 | Direct |
| May 20, 2026 | ATRC AtriCure, Inc. | Sale(S) | 3,000 | $28.65 | $85,950 | Direct |
| May 18, 2026 | ATRC AtriCure, Inc. | Award(A) | 6,144 | - | $0 | Direct |
| Feb 11, 2026 |  EMBC Embecta Corp. | Award(A) | 22,841 | - | $0 | Direct |
| Jan 9, 2026 | OM Outset Medical, Inc. | Award(A) | 18,667 | - | $0 | Direct |
| May 19, 2025 | ATRC AtriCure, Inc. | Award(A) | 5,401 | - | - | Direct |
| Apr 3, 2025 |  NVRO NEVRO CORP | Disposition(D) | 33,948 | - | - | Direct |
| Mar 5, 2025 | ATRC AtriCure, Inc. | Sale(S) | 6,100 | $38.12 | $232,532 | Direct |
| Feb 12, 2025 | EMBC Embecta Corp. | Award(A) | 13,839 | - | - | Direct |
1-10 of 10 transactions
About Prange Karen
Prange Karen (SEC CIK 0001566083) files insider reports with the SEC as Director of AtriCure, Inc. (ATRC), Director of Outset Medical, Inc. (OM) and Director of Embecta Corp. (EMBC). Signal8 also holds filings tied to 1 other company.
Signal8 holds 11 ownership filings by Prange Karen (1 Form 3, 10 Form 4), filed between Feb 14, 2025 and Aug 7, 2026. Those filings report 10 transactions, from Feb 12, 2025 to Aug 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Prange Karen's filings is in MASON, OH.
Recent filings by Prange Karen
- Aug 5, 2026: Open-market sale of ATRC shares (Form 4, code S).
- Jun 4, 2026: Grant or award of OM shares (Form 4, code A).
- May 20, 2026: Open-market sale of ATRC shares (Form 4, code S).
- May 18, 2026: Grant or award of ATRC shares (Form 4, code A).
- Feb 11, 2026: Grant or award of EMBC shares (Form 4, code A).
Other insiders filing for AtriCure, Inc. (ATRC)
- Privitera Salvatore, Chief Technical Officer
- GROVES REGINA E, Director
- Dahlquist Karl S., Chief Legal Officer
- Yuen Maggie, Director
- CARREL MICHAEL H, President, CEO, & Director
- Doraiswamy Vinayak, Chief Scientific Officer